✨ Your Portfolio is fetched and updated from zerodha.
Micro Miscellaneous

Mono Pharmacare Ltd.

MONOPHARMA

Market Cap
₹43 Cr.
P/E
17.62

Mono Pharmacare Ltd.

  • Mono Pharmacare
  • Yarn Syndicate
  • Shrenik
FAQs on Mono Pharmacare Ltd. Shareprice

Mono Pharmacare has given lower returns compared to its competitors.
Mono Pharmacare has grown at ~-47.07% over the last 1yrs while peers have grown at a median rate of -20.0%

Mono Pharmacare is not expensive.
Latest PE of Mono Pharmacare is 17.62, while 3 year average PE is 23.92.
Also latest EV/EBITDA of Mono Pharmacare is 8.28 while 3yr average is 9.08.

View FAQ's On Business
Growth Table
  • Mono Pharmacare Ltd.
  • Yarn Syndicate
  • Shrenik
Balance Sheet
  • Mono Pharmacare Ltd.
  • Yarn Syndicate
  • Shrenik
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Mono Pharmacare Ltd.
  • Yarn Syndicate
  • Shrenik
Cash Flow
  • Mono Pharmacare Ltd.
  • Yarn Syndicate
  • Shrenik
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Mono Pharmacare Ltd.
  • Yarn Syndicate
  • Shrenik
Quarterly Results
  • Mono Pharmacare Ltd.
  • Yarn Syndicate
  • Shrenik
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Mono Pharmacare Ltd. Financials

Balance sheet of Mono Pharmacare is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Mono Pharmacare is increasing.
Latest debt of Mono Pharmacare is ₹48.58 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹40.95 Crs.

Yes, profit is increasing.
The profit of Mono Pharmacare is ₹2.89 Crs for TTM, ₹2.44 Crs for Mar 2024 and ₹0.7 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Mono Pharmacare latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech